Market Overview

Benzinga's Top Upgrades, Downgrades For January 5, 2018

Share:

Top Upgrades

  • Analysts at Bank of America upgraded Cisco Systems, Inc. (NASDAQ: CSCO) from Neutral to Buy. Cisco shares rose 1.38 percent to $39.53 in pre-market trading.
  • Barclays upgraded Target Corporation (NYSE: TGT) from Underweight to Equal-Weight. Target shares climbed 0.84 percent to $66.40 in pre-market trading.
  • Analysts at Barclays upgraded Lowe's Companies, Inc. (NYSE: LOW) from Equal-Weight to Overweight. Lowe's shares gained 1 percent to $93.66 in pre-market trading.
  • RBC Capital upgraded Boston Scientific Corporation (NYSE: BSX) from Outperform to Top Pick. Boston Scientific shares dropped 0.04 percent to close at $25.32 on Thursday.
  • Analysts at Argus upgraded Eli Lilly and Co (NYSE: LLY) from Hold to Buy. Eli Lilly shares closed at $85.52 on Thursday.
  • Analysts at Goldman Sachs upgraded Xilinx, Inc. (NASDAQ: XLNX) from Neutral to Buy. Xilinx shares rose 2.45 percent to $72.22 in pre-market trading.
  • PiperJaffray upgraded U.S. Bancorp (NYSE: USB) from Neutral to Overweight. US Bancorp shares rose 0.22 percent to $55.10 in pre-market trading.
  • Instinet upgraded Comerica Incorporated (NYSE: CMA) from Neutral to Buy. Comerica shares closed at $87.51 on Thursday.
  • Analysts at Baird upgraded United Technologies Corporation (NYSE: UTX) from Neutral to Outperform. United Technologies shares closed at $130.45 on Thursday.
  • JP Morgan upgraded Fiat Chrysler Automobiles NV (NYSE: FCAU) from Neutral to Overweight. Fiat Chrysler shares rose 2.23 percent to $21.11 in pre-market trading.


Top Downgrades

  • Evercore ISI Group downgraded Sabre Corp (NASDAQ: SABR) from Outperform to Underperform. Sabre shares closed at $20.89 on Thursday.
  • JP Morgan downgraded Masco Corp (NYSE: MAS) from Overweight to Neutral. Masco shares closed at $44.05 on Thursday.
  • Analysts at Baird downgraded Johnson Controls International plc (NYSE: JCI) from Outperform to Neutral. Johnson Controls shares closed at $39.85 on Thursday.
  • Analysts at Oppenheimer downgraded Synergy Pharmaceuticals Inc (NASDAQ: SGYP) from Outperform to Perform. Synergy Pharmaceuticals shares fell 3.28 percent to $2.36 in pre-market trading.
  • Wells Fargo downgraded Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) from Market Perform to Underperform. Teva Pharmaceutical dropped 1.94 percent to $19.20 in pre-market trading.
  • Citigroup downgraded Roku Inc (NASDAQ: ROKU) from Neutral to Sell. Roku shares fell 5.89 percent to $48.22 in pre-market trading.
  • Citigroup downgraded Trivago NV - ADR (NASDAQ: TRVG) from Buy to Neutral. trivago shares closed at $7.56 on Thursday.
  • Wedbush downgraded Wingstop Inc (NASDAQ: WING) from Outperform to Neutral. Wingstop shares dropped 1.15 percent to $40.28 in pre-market trading.
  • William Blair downgraded Illumina, Inc. (NASDAQ: ILMN) from Outperform to Market Perform. Illumina shares closed at $232.99 on Thursday.
  • Bank of America downgraded Celgene Corporation (NASDAQ: CELG) from Buy to Neutral. Celgene shares fell 0.63 percent to $106.01 in pre-market trading.


Top Initiations

  • Buckingham initiated coverage on Nike Inc (NYSE: NKE) with a Buy rating. The price target for Nike is set to $72. Nike shares closed at $63.44 on Thursday.
  • Leerink Swann initiated coverage on Regulus Therapeutics Inc (NASDAQ: RGLS) with an Outperform rating. The price target for Regulus Therapeutics is set to $2. Regulus Therapeutics shares closed at $1.18 on Thursday.
  • Credit Suisse initiated coverage on Williams Companies Inc (NYSE: WMB) with an Outperform rating. The price target for Williams is set to $36. Williams shares closed at $32.55 on Thursday.
  • Analysts at Credit Suisse initiated coverage on Phillips 66 Partners LP (NYSE: PSXP) with a Neutral rating. The price target for Phillips 66 Partners is set to $52. Phillips 66 Partners shares closed at $53.84 on Thursday.
  • Credit Suisse initiated coverage on Kinder Morgan Inc (NYSE: KMI) with an Outperform rating. The price target for Kinder Morgan is set to $23. Kinder Morgan shares closed at $19.01 on Thursday.
  • Analysts at Citigroup initiated coverage on CytomX Therapeutics Inc (NASDAQ: CTMX) with a Buy rating. The price target for CytomX Therapeutics is set to $40. CytomX Therapeutics shares closed at $22.87 on Thursday.
  • Analysts at BTIG Research initiated coverage on Myriad Genetics, Inc. (NASDAQ: MYGN) with a Buy rating. The price target for Myriad Genetics is set to $41. Myriad Genetics shares closed at $34.38 on Thursday.
  • BMO Capital initiated coverage on Core-Mark Holding Company, Inc. (NASDAQ: CORE) with a Market Perform rating. The price target for Core-Mark is set to $33. Core-Mark shares closed at $31.41 on Thursday.

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Pre-Market Outlook Analyst Ratings

 

Related Articles (CELG + BSX)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
GMLPReiterates10.0
JWNReiterates29.0
DSGXInitiates Coverage On43.0
ZMAssumes115.0
LOGMAssumes77.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

This Day In Market History: Ford Doubles Minimum Wage, Slashes Workday

Aetna Acquisition Puts CVS Growth Prospects Back In Good Health